Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Predictive Model of Antibody Binding in the Presence of IgG-Interacting Bacterial Surface Proteins. | Front Immunol | 2021 | 33828549 | PubTator, text mining | PubMed |
| Insight into the human pathodegradome of the V8 protease from Staphylococcus aureus. | Cell Rep | 2021 | 33826899 | PubTator, text mining | PubMed |
| Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study. | Epidemiol Infect | 2021 | 33814028 | PubTator, text mining | PubMed |
| Reducing neutrophil exposure to oxygen allows their basal state maintenance. | Immunol Cell Biol | 2021 | 33811670 | PubTator, text mining | PubMed |
| Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients. | Cancers (Basel) | 2021 | 33809063 | PubTator, text mining | PubMed |
| The Potentials of Melatonin in the Prevention and Treatment of Bacterial Meningitis Disease. | Molecules | 2021 | 33808027 | PubTator, text mining | PubMed |
| Understanding the Future Prospects of Synergizing Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery with Ceramics and Regenerative Cellular Therapies. | Int J Mol Sci | 2021 | 33807361 | PubTator, text mining | PubMed |
| Protein Disulphide Isomerase and NADPH Oxidase 1 Cooperate to Control Platelet Function and Are Associated with Cardiometabolic Disease Risk Factors. | Antioxidants (Basel) | 2021 | 33806982 | PubTator, text mining | PubMed |
| Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature. | Medicina (Kaunas) | 2021 | 33806169 | PubTator, text mining | PubMed |
| A Hyaluronan and Platelet-Rich Plasma Hydrogel for Mesenchymal Stem Cell Delivery in the Intervertebral Disc: An Organ Culture Study. | Int J Mol Sci | 2021 | 33803999 | PubTator, text mining | PubMed |
| Complement in Tumourigenesis and the Response to Cancer Therapy. | Cancers (Basel) | 2021 | 33802004 | PubTator, text mining | PubMed |
| Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids. | Int J Mol Sci | 2021 | 33800815 | PubTator, text mining | PubMed |
| Plasma proteomic screening and validation of novel biomarkers in Takayasu's arteritis. | Clin Exp Rheumatol | 2021 | 33769262 | PubTator, text mining | PubMed |
| Physiological changes and transcriptome profiling in Saccharum spontaneum L. leaf under water stress and re-watering conditions. | Sci Rep | 2021 | 33750876 | PubTator, text mining | PubMed |
| Transcriptome analysis of sinensetin-treated liver cancer cells guided by biological network analysis. | Oncol Lett | 2021 | 33747212 | PubTator, text mining | PubMed |
| Editorial: The Role of Complement in Microbial Infections. | Front Immunol | 2021 | 33746982 | PubTator, text mining | PubMed |
| Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State. | Front Mol Neurosci | 2021 | 33746710 | PubTator, text mining | PubMed |
| Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past. | Int J Med Sci | 2021 | 33746606 | PubTator, text mining | PubMed |
| Hijacking Factor H for Complement Immune Evasion. | Front Immunol | 2021 | 33717083 | PubTator, text mining | PubMed |
| Quantitative Proteomics Reveals that the OGT Interactome Is Remodeled in Response to Oxidative Stress. | Mol Cell Proteomics | 2021 | 33716169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=48